Teva Pharmaceutical Industries Limited
News and overview for Teva Pharmaceutical Industries Limited
Teva Reports Third Quarter 2009 Results [Press Release]
Business Wire | 20 days 2 hours 11 minutes ago
Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) today reported results for the quarter ended September 30, 2009.
Teva Pharmaceutical receives FDA approval for generic version of heartburn drug Prevacid
Orlando Sentinel (Fla.) | 12 days 10 hours 37 minutes ago
NEW YORK (AP) — Teva Pharmaceutical Industries Ltd. said Tuesday the Food and Drug Administration approved its generic version of the heartburn drug Prevacid .
Rexahn Pharmaceuticals Provides Third Quarter 2009 Business Update [Press Release]
Business Wire | 5 days 19 hours 41 minutes ago
Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today provided an update on the company’s business for the 2009 third quarter.
Critical Alerts for American Express, Walgreen's, Teva Pharmaceuticals, China Life Insurance, and Dendreon Released by Seven Summits Research [Press Release]
PRNewswire | 87 days 19 hours 9 minutes ago
...American Express, Walgreen's, Teva Pharmaceuticals, China Life...PriceWatch Alerts for AXP, WAG, TEVA, LFC, and DNDN. Seven...Express Company , Walgreen Co. , Teva Pharmaceutical Industries Limited , China Life Insurance Co...
Critical Alerts for Freeport McMoRan, Yahoo!, BB&T, Teva, and Mechel Released by Seven Summits Research [Press Release]
PRNewswire | 46 days 19 hours 7 minutes ago
...McMoRan, Yahoo!, BB&T, Teva, and Mechel Released by Seven...Alerts for FCX, YHOO, BBT, TEVA, and MTL. Seven Summits...Yahoo! Inc. , BB & T Corp. , Teva Pharmaceutical Industries Limited , and Mechel OAO . In today...
The First Israel Fund, Inc. Announces Performance Data and Portfolio Composition [Press Release]
PRNewswire | 20 days 9 hours 4 minutes ago
...representing 68.8% of net assets, were: Stock Percent of Net Assets Teva Pharmaceutical Industries Limited 11.7 United Mizrahi Bank Limited 9.9 Israel Chemicals Limited 9.8 Bezeq The Israeli Telecommunication Corporation Limited 9.5 Check...
Cephalon, Barr settle patent dispute over pain treatment Fentora
Orlando Sentinel (Fla.) | 10 days 9 hours 14 minutes ago
NEW YORK (AP) — Cephalon Inc. will give Barr Pharmaceuticals Inc. a license to sell a generic version of the pain drug Fentora in 2018 as part of a patent lawsuit settlement, according to a Securities and Exchange Commission filing Thursday.
Sandoz will be able to sell authorized generic of ADHD drug under settlement with Shire -- South Florida Sun-Sentinel.com
Sun-Sentinel (Fort Lauderdale, Fla.) | 40 days 15 hours 48 minutes ago
NEW YORK (AP) — Irish drugmaker Shire PLC said Tuesday it settled patent lawsuits against Novartis AG's Sandoz unit, which was trying to market a generic version of Shire's attention deficit hyperactivity disorder drug Adderall XR.
Sandoz will be able to sell authorized generic of ADHD drug under settlement with Shire
Orlando Sentinel (Fla.) | 40 days 15 hours 50 minutes ago
NEW YORK (AP) — Irish drugmaker Shire PLC said Tuesday it settled patent lawsuits against Novartis AG's Sandoz unit, which was trying to market a generic version of Shire's attention deficit hyperactivity disorder drug Adderall XR.
Research and Markets: This Essential Report Analyzing the Global Pharmaceutical Industry is Now Available [Press Release]
Business Wire | 38 days 17 hours 38 minutes ago
Research and Markets (http://www.researchandmarkets.com/research/a9d8ff/analyzing_the_glob) has announced the addition of the "Analyzing the Global Pharmaceutical Industry" report to their offering.
Reportlinker Adds Prescription Drugs Report [Press Release]
PRNewswire | 75 days 18 hours 9 minutes ago
...Pfizer, Inc., Ranbaxy Laboratories Limited, Sanofi-Aventis SA, Sanofi Pasteur, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Watson Pharmaceuticals, Inc...
11 Stocks to End Year 'Strongly': Chief Investor
CNBC | 24 days 11 hours 8 minutes ago
Markets rose on Thursday after data showed the economy grew more than expected last quarter and jobless claims fell. How should investors be positioning their portfolios now?
Study Demonstrates That QVAR(R) is More Cost-Effective Than Other Inhaled Corticosteroid (ICS) Asthma Therapy Options [Press Release]
PRNewswire | 67 days 20 hours 9 minutes ago
...fluticasone CFC." Teva offers QVAR(R...for research by the pharmaceutical industry, clinical...includes, but is not limited to, headache (12...for treatment. Teva Pharmaceutical Industries Ltd., headquartered...
SHIRE PLC - Half Yearly Report [Press Release]
PRNewswire | 93 days 17 hours 9 minutes ago
Half Yearly Report
Children's Hospital in Colorado Rounds off List of 24 Cord Blood Transplant Centers Worldwide Enrolling for ExCell Trial Studying StemEx(R) for Leukemia and Lymphoma [Press Release]
PRNewswire | 67 days 21 hours 8 minutes ago
DENVER, Colorado and JERUSALEM, September 16 /PRNewswire/ -- Children's Hospital of Colorado and the Gamida Cell-Teva Joint Venture announced today that Children's Hospital is enrolling patients for the ExCell study. Children's Hospital is the 24th in a series of cord blood transplant sites worldwide, five of which are children's centers, participating in the study in the U.S., Spain, Italy, Hungary and Israel. The trial is researching the safety and efficacy of StemEx as a therapeutic tr...
Sign up for BIO SmartBrief
Company Overview
| Company: | Teva Pharmaceutical Industries Limited |
|---|---|
| Industry: | Generic Drugs |
| Website: | http://www.tevapharm.com |
The backbone of Teva Pharmaceutical Industries is its world-leading generic pharmaceuticals business. Through subsidiary Teva Pharmaceuticals USA, the company makes generic versions of hundreds of brand-name antibiotics, heart drugs, heartburn medications, and more. Teva's US generic products include equivalents of such blockbusters as antidepressant Prozac and osteoporosis drug Fosamax. The company, Israel's top drug maker, also develops and manufactures proprietary drugs, including multiple sclerosis treatment Copaxone, Parkinson's disease treatment Azilect, and a portfolio of women's health treatments. Its active pharmaceutical ingredients division makes drug components for Teva and other manufacturers.
Key Numbers
| Sales in U.S. Dollars (mil.) | 11,085 (2008) |
|---|---|
| One-year % Growth in Sales | 17.8 (2008) |
| Net Income in U.S. Dollars (mil.) | 635 (2008) |
| One-year % Growth in Net Income | -67.5 (2008) |
| Number of Employees | 38,307 (2008) |
| One-year % Growth in Number of Employees | 37.2 (2008) |
| Fiscal Year-End | December |